Clinical Trial Update: Regulation of Bone Formation in Renal Osteodystrophy [Phase 2]

View source ↗

Summary

Clinical Trial Update reports the completion of a Phase 2 trial investigating regulation of bone formation in renal osteodystrophy sponsored by NIDDK.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperparathyroidism
• Renal Osteodystrophy

Snippet

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: Secondary Hyperparathyroidism, Renal Osteodystrophy | Phase 2 | Status: COMPLETED